GOG GYN-LIVE Transistor (https://transistor.fm) https://feeds.transistor.fm/gog-gyn-live Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. From ovarian and uterine to cervical, vaginal, and vulvar malignancies, our investigators and institutions are at the forefront of innovation, shaping the future of cancer care. Each episode features leading experts, groundbreaking trial insights, and real-world stories that illuminate the evolving landscape of gynecologic oncology. Whether you're a clinician, researcher, patient advocate, or survivor, join us as we explore the science, the people, and the progress driving better outcomes and quality of life for patients everywhere. © 2026 The GOG Foundation, Inc. 612fd77a-f67c-52d3-afd7-813fc32c4e80 yes Support this podcast en Thu, 02 Apr 2026 16:27:04 -0400 Thu, 02 Apr 2026 16:27:12 -0400 https://img.transistorcdn.com/sKGupVfq2nNJsCXDHtxnXQIvAAfty41l0lCeLQYIkag/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iY2Iw/YTI3MWRhNmFhZGEy/ZDQxNTRkZWEwYTYw/MzY2Ny5wbmc.jpg GOG GYN-LIVE episodic The GOG Foundation, Inc. Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. From ovarian and uterine to cervical, vaginal, and vulvar malignancies, our investigators and institutions are at the forefront of innovation, shaping the future of cancer care. Each episode features leading experts, groundbreaking trial insights, and real-world stories that illuminate the evolving landscape of gynecologic oncology. Whether you're a clinician, researcher, patient advocate, or survivor, join us as we explore the science, the people, and the progress driving better outcomes and quality of life for patients everywhere. Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer Lindsey Moeller, Associate Director of Communications No No Accrual Culture: Top Points for Site Selection - Timelines 24 24 Accrual Culture: Top Points for Site Selection - Timelines full 03e9f132-9a28-4d08-a423-18bdf8ee3f35 https://share.transistor.fm/s/c4c81d47 The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:
Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem

★ Support this podcast ★ ]]> The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:
Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem

★ Support this podcast ★ ]]> Thu, 02 Apr 2026 16:26:44 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 1257 The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:
Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Accrual Culture: Top Points for Site Selection - Responsiveness 23 23 Accrual Culture: Top Points for Site Selection - Responsiveness full 19a3ec09-be49-4e9d-8a91-caaf6e89c7f7 https://share.transistor.fm/s/f53cad78 Fri, 06 Mar 2026 14:48:03 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 1065 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No GOG-3101 | TroFuse-20 Clinical Trial Update 22 22 GOG-3101 | TroFuse-20 Clinical Trial Update full 1d6d2c9d-3cd2-4bdb-b09a-d5537fd89920 https://share.transistor.fm/s/22608ce2 In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

★ Support this podcast ★ ]]> In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

★ Support this podcast ★ ]]> Thu, 05 Mar 2026 13:58:41 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 780 In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No The GOG Highlight Reel - January 2026 21 21 The GOG Highlight Reel - January 2026 full b9e500d6-593d-41bb-bdf2-3203d4c97a8b https://share.transistor.fm/s/92100cc1 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year.  

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course examines recent clinical trial data in gynecologic malignancies, offering insights on data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians in comprehending the evolving treatment landscape, including understanding trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions will focus on emerging approved therapies and investigational agents, with an intent to provide insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: GSK, Merck, AbbVie, AstraZeneca, Corcept Therapeutics, Verastem, Eisai, Natera, Karyopharm Therapeutics, BioNTech

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Gilead, Faeth Therapeutics

★ Support this podcast ★ ]]> The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year.  

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course examines recent clinical trial data in gynecologic malignancies, offering insights on data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians in comprehending the evolving treatment landscape, including understanding trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions will focus on emerging approved therapies and investigational agents, with an intent to provide insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: GSK, Merck, AbbVie, AstraZeneca, Corcept Therapeutics, Verastem, Eisai, Natera, Karyopharm Therapeutics, BioNTech

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Gilead, Faeth Therapeutics

★ Support this podcast ★ ]]> Fri, 20 Feb 2026 14:12:55 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 8151 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year.  

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course examines recent clinical trial data in gynecologic malignancies, offering insights on data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians in comprehending the evolving treatment landscape, including understanding trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions will focus on emerging approved therapies and investigational agents, with an intent to provide insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: GSK, Merck, AbbVie, AstraZeneca, Corcept Therapeutics, Verastem, Eisai, Natera, Karyopharm Therapeutics, BioNTech

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Gilead, Faeth Therapeutics

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No KEYNOTE-B96 FDA APPROVAL REVIEW 20 20 KEYNOTE-B96 FDA APPROVAL REVIEW full edf56de2-7bfe-4861-9359-de91961f9dff https://share.transistor.fm/s/d52cae2e Mon, 16 Feb 2026 11:08:02 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 1190 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Accrual Culture: Top Points for Site Selection - Feasibility 19 19 Accrual Culture: Top Points for Site Selection - Feasibility full 38571126-c98f-4beb-88f6-802ccdc2b9a6 https://share.transistor.fm/s/e136e553 Thu, 05 Feb 2026 14:17:35 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 910 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Accrual Culture: Top Points for Site Selection - Enrollement 17 17 Accrual Culture: Top Points for Site Selection - Enrollement full 52691694-ff46-4480-ba66-d9b8e55914d0 https://share.transistor.fm/s/f4db1b12 The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> Fri, 30 Jan 2026 17:38:02 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 1101 The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> Accrual Culture, GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Oncology No 2026 Cervical Cancer Awareness Month Wrap Up 18 18 2026 Cervical Cancer Awareness Month Wrap Up full ef1102e6-f6cf-4090-a528-9f67898f62eb https://share.transistor.fm/s/1208b307 Fri, 30 Jan 2026 17:35:37 -0500 The GOG Foundation, Inc. The GOG Foundation, Inc. 693 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No GOG Highlight Reel - January 2025 12 12 GOG Highlight Reel - January 2025 full d6d745e5-4795-47e5-968d-624d70298440 https://share.transistor.fm/s/5f88f435 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. A twice-yearly event, our most recent program took place Saturday, January 18, 2025, in Phoenix, Arizona alongside the 2025 NRG Oncology Winter Meeting.

The GOG Highlight reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon Therapeutics, AstraZeneca, Corcept Therapeutics, GSK, and Eisai.

The GOG Foundation, Inc., would also like to thank our sponsors for this symposium: Pfizer/Genmab and GSK.

★ Support this podcast ★ ]]> The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. A twice-yearly event, our most recent program took place Saturday, January 18, 2025, in Phoenix, Arizona alongside the 2025 NRG Oncology Winter Meeting.

The GOG Highlight reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon Therapeutics, AstraZeneca, Corcept Therapeutics, GSK, and Eisai.

The GOG Foundation, Inc., would also like to thank our sponsors for this symposium: Pfizer/Genmab and GSK.

★ Support this podcast ★ ]]> Thu, 16 Oct 2025 14:39:02 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 9193 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. A twice-yearly event, our most recent program took place Saturday, January 18, 2025, in Phoenix, Arizona alongside the 2025 NRG Oncology Winter Meeting.

The GOG Highlight reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon Therapeutics, AstraZeneca, Corcept Therapeutics, GSK, and Eisai.

The GOG Foundation, Inc., would also like to thank our sponsors for this symposium: Pfizer/Genmab and GSK.

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Research Algorithms, Clinical Trial Prioritization(s), Sequencing of Trials/Treatment 11 11 Research Algorithms, Clinical Trial Prioritization(s), Sequencing of Trials/Treatment full 9b2299c7-5a47-47ad-a273-dadf813e1c4e https://share.transistor.fm/s/ed24f69d Wed, 15 Oct 2025 15:22:12 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 900 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No The Ten Keys to Success When Building Your Clinical Trial Network 10 10 The Ten Keys to Success When Building Your Clinical Trial Network full 2b2fde88-0217-45ad-987c-698e9ca4e3a9 https://share.transistor.fm/s/b4ee0bbb Wed, 15 Oct 2025 15:20:54 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 2472 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Budget and Contract Management; Strategic Insights on Maneuvering Through your Legal and Finance Discussions 9 9 Budget and Contract Management; Strategic Insights on Maneuvering Through your Legal and Finance Discussions full d4c058c5-f780-4deb-b983-c26f3b997b5f https://share.transistor.fm/s/2dc07c93 Wed, 15 Oct 2025 15:19:54 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 1954 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Quality Management Processes - Large Sites 8 8 Quality Management Processes - Large Sites full 40ca25af-ff97-4304-8222-01260e459a2b https://share.transistor.fm/s/3eebb007 Wed, 15 Oct 2025 15:18:34 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 2107 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Enrollment and Accrual 7 7 Enrollment and Accrual full c91fc3ef-0d89-43c4-91ed-f3a4b022b7e0 https://share.transistor.fm/s/d2c62c24 Wed, 15 Oct 2025 15:17:11 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 1124 GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No The GOG Highlight Reel - July 2025 2 2 The GOG Highlight Reel - July 2025 full 51dded72-2d4e-40e4-a80f-0cbf40330dc1 https://share.transistor.fm/s/a7b80852 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. This twice-yearly event was most recently held on Saturday, July 26, 2025, in Washington D.C. alongside the 2025 NRG Oncology Summer Meeting.

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon, AstraZeneca, Corcept Therapeutics, Genelux, Gilead, GSK and Karyopharm

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Pfizer Oncology | Genmab, GSK, and Verastem

★ Support this podcast ★ ]]> The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. This twice-yearly event was most recently held on Saturday, July 26, 2025, in Washington D.C. alongside the 2025 NRG Oncology Summer Meeting.

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon, AstraZeneca, Corcept Therapeutics, Genelux, Gilead, GSK and Karyopharm

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Pfizer Oncology | Genmab, GSK, and Verastem

★ Support this podcast ★ ]]> Wed, 15 Oct 2025 14:47:18 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 8939 The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. This twice-yearly event was most recently held on Saturday, July 26, 2025, in Washington D.C. alongside the 2025 NRG Oncology Summer Meeting.

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon, AstraZeneca, Corcept Therapeutics, Genelux, Gilead, GSK and Karyopharm

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Pfizer Oncology | Genmab, GSK, and Verastem

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No Accrual Culture: The Four Components of A Successful Clinical Trial Network 1 1 Accrual Culture: The Four Components of A Successful Clinical Trial Network full fd52baef-e730-4be2-adfc-e933f7240627 https://share.transistor.fm/s/8a28abc4 The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> Thu, 09 Oct 2025 16:23:40 -0400 The GOG Foundation, Inc. The GOG Foundation, Inc. 677 The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★ ]]> GOG, GOG Foundation, GOG Partners, Clinical Trials, Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Uterine Cancer No